Investors – Race Oncology

Investors

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

ASX Announcements

Reports

Title	Link
Annual Report 2022	Download
Race Oncology - Pitt Street Research Initiation Report - October 2022	Download
Bisantrene Combo Poster	Download
The Rediscovery of Bisantrene: A Review of the Literature	Download

Presentations

Title	Link
Race Oncology AGM 2022 Presentation	Download
Race Oncology AGM 2021 Presentation	Download
Race Oncology AGM 2020 Presentation	Download

Corporate Governance

Title	Link
Corporate Governance Plan	Download
Corporate Governance Statement	Download
Board of Directors' Skills Matrix	Download
Replacement Constitution	Download

Share Price

Latest News

Race Oncology EMD AML Trial Featured on NBN News

Posted on 17 November 2022 by Daniel Tillett / 0 comments

Race Oncology Investor Briefing – Melbourne 20th Oct 2022

Posted on 2 November 2022 by Daniel Tillett / 0 comments

September 2022 Quarterly Activity Report & Appendix 4C

Posted on 27 October 2022 by Daniel Tillett / 0 comments

Pitt St Research interview with Race Oncology’s CEO Phil Lynch & CSO Dr Daniel Tillett

Posted on 26 October 2022 by Daniel Tillett / 0 comments

Pitt Street Research Initiates Coverage of Race Oncology

Posted on 17 October 2022 by Daniel Tillett / 0 comments

Race Oncology Limited (ASX:RAC) is an Australian pharmaceutical company focused on the development o…

Race Oncology

Targeting Zantrene® towards better cancer outcomes

Contact Us